Literature DB >> 8496868

Relationships between social background and medical care in osteoarthritis.

P Dexter1, K Brandt.   

Abstract

Arthritis is relatively more prevalent among those of low socioeconomic status and it is important that this group have access to good arthritis care. In our study looking at relationships between socioeconomic status and medical care, histories were obtained from a convenience sample of 110 community living elderly persons of varying social backgrounds who had symptomatic osteoarthritis (OA) of the hip and/or knee. Almost all subjects had seen a physician at some time for their OA, and low income and black subjects were twice as likely to be currently receiving OA care as others. However, in looking at instruction and monitoring in relation to therapeutic joint exercises as a qualitative aspect of medical care, subjects who had both above mean OA impairment and more than a high school education were found to have received much more comprehensive care than any other subgroup.

Entities:  

Mesh:

Year:  1993        PMID: 8496868

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

1.  Clinician's Commentary on Winter Di Cola et al.(1.).

Authors:  Linda Li
Journal:  Physiother Can       Date:  2014       Impact factor: 1.037

2.  A population study of factors associated with general practitioner consultation for non-inflammatory musculoskeletal pain.

Authors:  K B Hagen; A Bjørndal; T Uhlig; T K Kvien
Journal:  Ann Rheum Dis       Date:  2000-10       Impact factor: 19.103

Review 3.  The attitudes, beliefs and behaviours of GPs regarding exercise for chronic knee pain: a systematic review.

Authors:  Elizabeth Cottrell; Edward Roddy; Nadine E Foster
Journal:  BMC Fam Pract       Date:  2010-01-18       Impact factor: 2.497

Review 4.  Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management.

Authors:  Angel M Reyes; Jeffrey N Katz
Journal:  Rheum Dis Clin North Am       Date:  2020-10-29       Impact factor: 2.670

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.